These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 885973)

  • 1. Quantitative analysis of trifluoroacetic acid in body fluids of patients treated with halothane.
    Witte L; Nau H; Fuhrhop JH; Doenicke A; Grote B
    J Chromatogr; 1977 Jul; 143(4):329-34. PubMed ID: 885973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterification of trifluoroacetic acid with phenyldiazomethane for quantitative gas chromatographic analysis. Methods involving separation from biological materials.
    Karashima D; Shigematsu A; Furukawa T
    J Chromatogr; 1977 Jan; 130():77-86. PubMed ID: 853094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas-chromatographic method for the halothane metabolites, trifluoroacetic acid and bromide, in biological fluids.
    Maiorino RM; Gandolfi AJ; Sipes IG
    J Anal Toxicol; 1980; 4(5):250-4. PubMed ID: 7442137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gas chromatographic mass spectrometric determination of trifluoroacetic acid in biological fluid. Application to halothane metabolism.
    Karashima D; Takahashi S; Shigematsu A; Furukawa T; Kuhara T
    Biomed Mass Spectrom; 1976 Feb; 3(1):41-4. PubMed ID: 4173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gas chromatographic mass spectrometric method for the analysis of trifluoroacetic acid: application to the metabolism of halothane by in vitro preparations.
    Gruenke LD; Waskell LA
    Biomed Environ Mass Spectrom; 1988 Dec; 17(6):471-5. PubMed ID: 3240374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of trifluoroacetate in the urine and blood by isotachophoresis.
    Morio M; Fujii K; Takiyama R; Chikasue F; Kikuchi H; Ribarić L
    Anesthesiology; 1980 Jul; 53(1):56-9. PubMed ID: 7386909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay.
    Gruenke LD; Konopka K; Koop DR; Waskell LA
    J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the halothane metabolites trifluoroacetic acid and bromide in plasma and urine by ion chromatography.
    Hankins DC; Kharasch ED
    J Chromatogr B Biomed Sci Appl; 1997 May; 692(2):413-8. PubMed ID: 9188831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of halothane concentration on trifluoroacetic acid excretion in urine.
    Takiyama R; Morio M; Fujii K; Kikuchi H; Yuge O; Chikasue F; Taira Y; Jordanov JG
    Hiroshima J Med Sci; 1985 Dec; 34(4):377-80. PubMed ID: 3830994
    [No Abstract]   [Full Text] [Related]  

  • 10. Analytical isotachophoresis utilizing computer simulation. II. Assessment of optimum separation conditions for urinary trifluoroacetic acid metabolized from anaesthetic halothane.
    Hirokawa T; Takemi H; Kiso Y; Takiyama R; Morio M; Fujii K; Kikuchi H
    J Chromatogr; 1984 Feb; 305(2):429-37. PubMed ID: 6707170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum conditions for formation of aflatoxin M1-trifluoroacetic acid derivative.
    Stubblefield RD
    J Assoc Off Anal Chem; 1987; 70(6):1047-9. PubMed ID: 3125145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary and biliary excretion of metabolites of halothane in dogs.
    Sakai T; Yoshida H; Fukui A; Takaori M
    Drug Metab Dispos; 1991; 19(2):419-22. PubMed ID: 1676647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of disulfiram, diethyldithiocarbamate and carbon disulfide on the metabolic formation of trifluoroacetic acid from halothane in the rat.
    Eckes L; Büch HP
    Arzneimittelforschung; 1985; 35(9):1447-51. PubMed ID: 3002400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane.
    Ilyin GP; Rissel M; Malledant Y; Tanguy M; Guillouzo A
    Biochem Pharmacol; 1994 Aug; 48(3):561-7. PubMed ID: 8068043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypersensitivity to a halothane metabolite on halothane-induced liver damage.
    Ford DJ; Coyle DE; Harrington JF
    Anesthesiology; 1984 Feb; 60(2):141-3. PubMed ID: 6696235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIFLUOROACETIC ACID AS METABOLITE OF HALOTHANE.
    STIER A
    Biochem Pharmacol; 1964 Nov; 13():1544. PubMed ID: 14239633
    [No Abstract]   [Full Text] [Related]  

  • 17. Biliary excretion of the halothane metabolite trifluoroacetic acid in infants.
    Wark H; Earl J; Chau D; Overton J
    Anaesth Intensive Care; 1991 May; 19(2):213-6. PubMed ID: 2069241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of halothane anesthesia and trifluoroacetic acid on protein binding of benzodiazepines.
    Suárez E; Aguilera L; Calvo R; Rodríguez-Sasiaín JM; Martínez-Jorda R
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):693-6. PubMed ID: 1770832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for antibodies associated with halothane hepatitis.
    Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
    Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of urochloralic acid, the glucuronic acid conjugate of trichloroethanol, by gas chromatography with electron-capture detection and its application to urine, plasma and liver.
    Ikeda M; Hattori H; Koyama Y; Ohmori S
    J Chromatogr; 1984 Apr; 307(1):111-9. PubMed ID: 6725477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.